Results 311 to 320 of about 547,472 (401)

CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

Advanced Science, EarlyView.
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He, Yuzhong Peng, Lat‐lun Leong, Jingbo Zhou, Dongyang Tang, Weilu Wang, Xiaoran Wu, Josh haipeng Lei, Yongqin Ye, Yangyang Feng, Yunfeng Qiao, Xiangpeng Chu, Di Mu, Qi Zhao, Tzuming Liu, Yan Chen, Paul Kwonghang Tam, Chu‐Xia Deng   +17 more
wiley   +1 more source

A Case of Synchronous Triple Primary Lung Cancers Composed of Adenocarcinoma, Squamous Cell Carcinoma and Large Cell Carcinoma in the Right Lung.

, 1996
Yuichiro Takeda, Masahiro Seike, Shigeto Kawachi, Tatsurou Watanabe, Shouji Kudoh, Hisanobu Niitani   +5 more
openalex   +2 more sources

Venous Gangrene in a Patient with Adenocarcinoma of the Lung [PDF]

, 2000
Mu Yang
openalex   +1 more source

Laeverin is Cell‐Surface Target for Liquid‐Phase Metastasizing Cancer Cells

Advanced Science, EarlyView.
This study revealed that epithelial cancer cells in the floating phase induce the expression of laeverin (LVRN) that is a trophoblast‐specific and cell‐surface immunoregulatory factor and showed that anti‐LVRN ADC is a promising agent that can attack cancer cells in the metastatic liquid phase and block further distant metastasis.
Haruki Kasama, Yuya Sakai, Kyosuke Kagami, Takashi Iizuka, Tatsuhito Kanda, Takuma Suzuki, Kayo Kayahashi, Masanori Ono, Tomoko Fujiwara, Shintaro Yagi, Noriyuki Inaki, Isao Matsumoto, Rena Yamazaki, Kaoru Abiko, Noriomi Matsumura, Akira Hattori, Takiko Daikoku, Hiroshi Fujiwara   +17 more
wiley   +1 more source

Semiquantitative immunoblot analysis of nm23‐H1 and ‐H2 isoforms in adenocarcinomas of the lung: Prognostic significance [PDF]

, 2000
Yuichi Sato, Benio Tsuchiya, Takeshi Urao, Hideo Baba, Hiroshi Shiku, Tetsuro Kodama, Toru Kameya   +6 more
openalex   +1 more source

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Journal of Clinical Oncology, 2015
M. Tsao, S. Marguet, G. Le Teuff, S. Lantuejoul, F. Shepherd, L. Seymour, R. Kratzke, S. Graziano, H. Popper, R. Rosell, J. Douillard, Thierry Le-Chevalier, J. Pignon, J. Soria, E. Brambilla   +14 more
semanticscholar   +1 more source

Lung adenocarcinoma

, 2016
openaire   +1 more source

Synergistic Anti‐Cancer Therapy Through Ultrasound‐Induced Piezocatalytic Therapy and Tumor Treatment Fields

Advanced Science, EarlyView.
A novel, wearable anti‐cancer platform synergistically combines tumor treating fields (TTFs) and piezocatalytic therapy (PCT) via ultrasound‐activated, lead‐free piezocomposites. This strategy efficiently suppresses tumor growth, modulates the immune microenvironment, and demonstrates strong therapeutic synergy in both mouse model of subcutaneous tumor
Jing Jin, Haoyue Xue, Keliang Chen, Yonglin Su, Xin Hu, Xiaolin Hu, Xing Huang, Laiming Jiang, Jiagang Wu, Xingchen Peng   +9 more
wiley   +1 more source

A Case of Small Peripheral Lung Adenocarcinoma with Remarkable Invasion of Bronchial Submucosal Lymph Ducts.

, 1998
Ko Tsuji, Takashi Hirano, Norihiko Kawate, Chimori Konaka, Yoshiro Ebihara, Harubumi Kato   +5 more
openalex   +2 more sources

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

Journal of Clinical Oncology, 2013
L. Sequist, J. Yang, N. Yamamoto, K. O'Byrne, V. Hirsh, T. Mok, Sarayut Lucien Geater, S. Orlov, C. Tsai, M. Boyer, W. Su, J. Bennouna, T. Kato, V. Gorbunova, K. Lee, R. Shah, D. Massey, V. Zazulina, M. Shahidi, M. Schuler   +19 more
semanticscholar   +1 more source